Comparing Falmina vs Lessina
| Falmina (ethinyl estradiol / levonorgestrel) | Lessina (ethinyl estradiol / levonorgestrel) |
|
|---|
| Falmina (ethinyl estradiol / levonorgestrel) | Lessina (ethinyl estradiol / levonorgestrel) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Endometriosis, Polycystic Ovary Syndrome, Abnormal Uterine Bleeding, Birth Control, Ovarian Cysts, Gonadotropin Inhibition, Premenstrual Syndrome. Falmina may also be used for purposes... View more |
Prescription only
Prescribed for Endometriosis, Polycystic Ovary Syndrome, Abnormal Uterine Bleeding, Birth Control, Ovarian Cysts, Gonadotropin Inhibition. Lessina may also be used for purposes not listed in this... View more |
Related suggestions Birth Control
Abnormal Uterine Bleeding
Endometriosis
|
|||||||||||||||
| More about Falmina (ethinyl estradiol / levonorgestrel) | More about Lessina (ethinyl estradiol / levonorgestrel) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Falmina has an average rating of 5.2 out of 10 from a total of 86 ratings on Drugs.com. 35% of reviewers reported a positive effect, while 42% reported a negative effect. |
Lessina has an average rating of 4.8 out of 10 from a total of 133 ratings on Drugs.com. 36% of reviewers reported a positive effect, while 49% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Falmina side effects |
View all Lessina side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Lower cost generic approved | Lower cost generic approved | ||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Falmina prices |
View all Lessina prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other ethinyl estradiol / levonorgestrel brands include: Afirmelle, Altavera, Amethia, Amethia Lo, Amethyst, Ashlyna, Aubra, Aubra EQ, Aviane, Ayuna, Balcoltra, Camrese, CamreseLo, Cerinta, Chateal, Chateal EQ, Daysee, Delyla, Dolishale, Elifemme, Enpresse, Fayosim, Iclevia, Introvale, Jaimiess, Jolessa, Joyeaux, Kurvelo, Larissia, Lessina, Levlen, Levonest, Levora, Lillow, Lo Simpesse, LoJaimiess, LoSeasonique, Lutera, Marlissa, Minzoya, Myzilra, Orsythia, Portia, Quartette, Rivelsa, Rosyrah, Seasonale, Seasonique, Setlakin, Simpesse, Sronyx, Trivora, Twirla, Tyblume, Vienva View more | Other ethinyl estradiol / levonorgestrel brands include: Afirmelle, Altavera, Amethia, Amethia Lo, Amethyst, Ashlyna, Aubra, Aubra EQ, Aviane, Ayuna, Balcoltra, Camrese, CamreseLo, Cerinta, Chateal, Chateal EQ, Daysee, Delyla, Dolishale, Elifemme, Enpresse, Falmina, Fayosim, Iclevia, Introvale, Jaimiess, Jolessa, Joyeaux, Kurvelo, Larissia, Levlen, Levonest, Levora, Lillow, Lo Simpesse, LoJaimiess, LoSeasonique, Lutera, Marlissa, Minzoya, Myzilra, Orsythia, Portia, Quartette, Rivelsa, Rosyrah, Seasonale, Seasonique, Setlakin, Simpesse, Sronyx, Trivora, Twirla, Tyblume, Vienva View more | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
45 hours |
45 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 494 drugs are known to interact with Falmina:
|
A total of 494 drugs are known to interact with Lessina:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
|
||||||||||||||||
| First Approval Date | |||||||||||||||||
|
March 28, 2012 |
N/A |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.